Moderna

CompanyUnited States

Moderna develops one asset, in human trials (intismeran autogene in melanoma). Mostly mrna; based in the United States.

1
Asset
Furthest stage
Human trials
0
Trials
1
Signal

Pipeline

1
  • intismeran autogene

    Encodes individualized tumor neoantigens to stimulate tumor-specific T-cell immune responses.

    Human trials, mRNA, melanoma, other cancers

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Signals1
  • Similar companies6

Intelligence